Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
|
|
Acasti Pharma Inc. (ACST)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Derby Michael (Director) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 12,500 options to buy
@ $2.64, valued at
$33k
|
|
| 07/18/2023 |
4
| Kavuru Vimal (Director) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 12,500 options to buy
@ $2.64, valued at
$33k
|
|
| 07/18/2023 |
4
| Olds Donald (Director) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 12,500 options to buy
@ $2.64, valued at
$33k
|
|
| 07/18/2023 |
4
| Macdonald R. Loch (Chief Medical Officer) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 60,000 options to buy
@ $2.64, valued at
$158.4k
|
|
| 07/18/2023 |
4
| D'Andrea Carrie (VP Clinical Operations) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 42,000 options to buy
@ $2.64, valued at
$110.9k
|
|
| 07/18/2023 |
4
| Kumar Amresh (VP Program Management) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 42,000 options to buy
@ $2.64, valued at
$110.9k
|
|
| 07/18/2023 |
4
| Kohli Prashant (CEO) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 208,334 options to buy
@ $2.64, valued at
$550k
|
|
| 09/30/2022 |
4
| Kavuru Vimal (Director) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 45,000 options to buy
@ $0 |
|
| 09/30/2022 |
4
| Olds Donald (Director) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 45,000 options to buy
@ $0 |
|
| 09/30/2022 |
4
| Canan John (Director) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 45,000 options to buy
@ $0 |
|
| 09/30/2022 |
4
| Derby Michael (Director) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 85,000 options to buy
@ $0 |
|
| 06/23/2022 |
4
| Lemieux Pierre (COO, Canada & CSO) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 165,000 options to buy
@ $0 |
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| D'Alvise Janelle (PRESIDENT & CEO) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 560,000 options to buy
@ $0 |
|
| 11/16/2021 |
4
| Olds Donald (Director) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 42,100 options to buy
@ $0 |
|
| 11/16/2021 |
4
| Lemieux Pierre (COO, Canada & CSO) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 287,900 options to buy
@ $0 |
|
| 11/16/2021 |
4
| Kavuru Vimal (Director) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 42,100 options to buy
@ $0 |
|
| 11/16/2021 |
4
| HASELTINE WILLIAM A (Director) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 42,100 options to buy
@ $0 |
|
| 11/16/2021 |
4
| Ford Brian D. (CFO) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 287,900 options to buy
@ $0 |
|
| 11/16/2021 |
4
| D'Alvise Janelle (PRESIDENT & CEO) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 655,500 options to buy
@ $0 |
|
| 11/16/2021 |
4
| Carter Roderick Noel (Director) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 42,100 options to buy
@ $0 |
|
| 11/16/2021 |
4
| Canan John (Director) has filed a Form 4 on Acasti Pharma Inc.|
Txns:
| Granted 42,100 options to buy
@ $0 |
|
|
|